Effect of Pilates Exercises on Menopausal Symptoms

What this trial studies

Menopause, a significant transition in a woman's life characterized by the cessation of menstruation and a decline in ovarian function, leads to reduced levels of estrogen and progesterone. This hormonal shift is associated with a range of symptoms that can adversely affect women's quality of life, including vasomotor symptoms such as hot flashes and night sweats, psychological symptoms like mood swings and depression, as well as urogenital symptoms such as vaginal dryness and sexual dysfunction. These symptoms, collectively referred to as menopausal symptoms, can vary in severity and duration and frequently require intervention to alleviate their impact on daily life.

Conditions in scope

• Menopausal
• Obese Patients
• Pilates Exercise
• Quality of Life and Menopause

Interventions

• reformer pilates group (Other) — Reformer Pilates exercises were applied to the pilates group twice a week for a total of 8 weeks.
• Mat pilates group (Other) — Mat Pilates exercises were applied to the pilates group twice a week for a total of 8 weeks.
• Lifestyle change group (Other) — After the doctor's check-up, routine application continued. The patient was informed about physical activity. In addition; a physical activity-based brochure prepared by the Specialist Physiotherapist was distributed to the participants in this group.

Who can join

Women only · Ages 45 Years to 65 Years

Inclusion criteria

• Women who have entered menopause
• Being diagnosed with obesity (30 kg/m2 ≤ BMI ≤ 40 kg/m2 )
• Having the physical or cognitive ability to exercise
• Being sedentary ('International Physical Activity Questionnaire' will be used. Those in the Inactive Category group will be included.)
• Those who agree to participate in the study

Exclusion criteria

• BMI below 30
• Those with serious heart disease, DM, kidney, liver, thyroid disease and cancer
• Those receiving hormone therapy
• Those using antipsychotic drugs
• Those using steroids and derivatives
• Those using insulin-sensitizing drugs
• Those with musculoskeletal diseases that will prevent exercise • Cognitive problems that will affect cooperation

Eligibility wording paraphrased from the public record. View the full criteria on ClinicalTrials.gov before contacting a site.

Where it’s happening

Status & timeline

• Overall status: Completed
• Study type: Interventional
• Phase: N/A
• Start date: 2023-09-05
• Primary completion: 2024-03-15
• Last update posted: 2025-05-30
• First posted: 2025-05-30

Sponsor & contact

Lead sponsor: Batman University (Other)

For trial site contact information, use the official record at ClinicalTrials.gov. Contact details change frequently and the public record is the source of truth.

Outcome measures

Primary outcomes

• Menopause Symptoms Assessment Scale (MSAS) (8 week)
  The Menopause Symptoms Assessment Scale (MSS) is a very useful tool for assessing the symptoms of women in menopause and measuring their impact on their quality of life. Using a Likert-type scale, determining the severity of symptoms provides important data for treatment and intervention planning. In particular, being organized in 3 sub-dimensions (somatic, psychological and urogenital complaints) helps understand the…
• Menopause-Specific Quality of Life Scale (MSQLS) (8 week)
  The Menopause-Specific Quality of Life Scale (MSQLS) is a comprehensive tool that multi-dimensionally assesses the quality of life of women in the menopausal process. Developed by Hilditch and colleagues, this scale focuses on the physical, psychosocial, sexual and vasomotor symptoms of menopause, revealing the impact of different symptoms on quality of life in more detail. Especially the Likert-type assessment consisting…

Related ClearedRx care

If you’re reading this trial because you have menopause symptoms now, you don’t have to wait for a trial to access evidence-based care. ClearedRx prescribes the same FDA-approved and compounded HRT products that have been studied in trials like this one for decades.